Synovus Financial Corp increased its holdings in shares of Danaher Co. (NYSE:DHR) by 1.0% in the fourth quarter, HoldingsChannel reports. The firm owned 93,624 shares of the conglomerate’s stock after purchasing an additional 935 shares during the quarter. Synovus Financial Corp’s holdings in Danaher were worth $8,684,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of DHR. GQG Partners LLC bought a new stake in Danaher during the 2nd quarter worth approximately $101,000. Zions Bancorporation increased its stake in Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after purchasing an additional 667 shares in the last quarter. Patten Group Inc. increased its stake in Danaher by 262.3% during the 3rd quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 3,497 shares in the last quarter. First Personal Financial Services boosted its position in Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after acquiring an additional 691 shares during the last quarter. Finally, Calton & Associates Inc. acquired a new position in Danaher during the 4th quarter worth approximately $114,000. 77.05% of the stock is owned by institutional investors and hedge funds.
In related news, EVP William K. Daniel sold 131,066 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.05, for a total value of $13,375,285.30. Following the sale, the executive vice president now owns 270,523 shares in the company, valued at approximately $27,606,872.15. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Angela S. Lalor sold 42,988 shares of the stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $102.29, for a total value of $4,397,242.52. Following the completion of the sale, the senior vice president now owns 82,008 shares in the company, valued at approximately $8,388,598.32. The disclosure for this sale can be found here. In the last 90 days, insiders sold 237,043 shares of company stock worth $24,194,886. 12.20% of the stock is owned by company insiders.
Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. During the same quarter in the prior year, the firm posted $1.05 EPS. The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. analysts forecast that Danaher Co. will post 4.37 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date was Thursday, December 28th. Danaher’s dividend payout ratio (DPR) is presently 15.86%.
A number of research firms have weighed in on DHR. Cowen reaffirmed a “buy” rating and set a $110.00 price target on shares of Danaher in a research report on Tuesday, January 30th. Credit Suisse Group upped their price target on Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Royal Bank of Canada reaffirmed a “hold” rating and set a $98.00 price target on shares of Danaher in a research report on Wednesday, January 31st. Stifel Nicolaus upped their price target on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Finally, Morgan Stanley upped their price target on Danaher from $103.00 to $110.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 31st. One analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Danaher currently has an average rating of “Buy” and an average target price of $100.68.
WARNING: This piece was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2018/02/20/synovus-financial-corp-boosts-position-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.